Built to WCAG 2.2 AA (9:1 Contrast Override) • ADA Title II • Section 508 (Diseñado bajo estándares WCAG 2.2 AA para la Comunidad de AWC)

Mod 09 Discussion: Medical Clearance & Heart Safety Rules

Risk Stratification, Hemodynamic Responses, & PAGA Federal Mandates

Prescribing exercise for individuals managing cardiovascular pathologies (such as ischemic heart disease, heart failure, and hypertension) requires precise clinical auditing. Standard aerobic and resistance targets must be balanced against hemodynamic safety limits (avoiding extreme systolic pressure spikes or exertional hypotension) and medical therapy interactions (such as beta-blocker chronotropic blunting).

In this discussion, you will audit how federal standards in the Physical Activity Guidelines for Americans (PAGA 2018, 2nd Ed.) guide risk stratification, blood pressure management, and clinical exercise safety across your chosen Build Your Own Journey Track.

Discussion Schedule & Deadlines / Horario y Fechas Límite:

Topic Opens / Apertura del Foro: Tuesday at 12:00 AM MST / Martes a las 12:00 AM MST
Initial Post Due / Publicación Inicial: Thursday at 11:59 PM MST / Jueves a las 11:59 PM MST
Peer Replies Due / Respuestas a Compañeros: Sunday at 11:59 PM MST / Domingo a las 11:59 PM MST
Board Closes / Cierre del Foro: Monday at 11:59 PM MST / Lunes a las 11:59 PM MST

Bilingual Participation Welcome / Participación Bilingüe Bienvenida: You are warmly encouraged to post in English or Spanish according to your preference. Le animamos a publicar en inglés o en español, según su preferencia.

Phase 1: Select Your Clinical Simulation Case File #265-09

Choose ONE of the three career-aligned tracks below to copy into your AI prompt query:

Track 1: Clinical & Rehabilitation Path / Ruta Clínica y Rehabilitación

Focus: Outpatient cardiac rehabilitation; auditing hemodynamic response, beta-blocker chronotropic blunting, and RPE regulation in a patient with stable ischemic heart disease and Stage 2 hypertension.

###
[TRACK]: Track 1 - Clinical & Rehabilitation Path
[PATIENT INITIALS]: M.K. | [AGE]: 62 | [LOCATION]: Yuma, AZ
[DIAGNOSIS]: Stable Ischemic Heart Disease & Stage 2 Hypertension (148/92 mmHg).
[MEDICATIONS]: Metoprolol (beta-blocker) & Lisinopril.
[CLINICAL ISSUE]: Resting HR is 54 bpm due to beta-blockade; patient requires RPE-based intensity monitoring (Borg 6–20 scale) and strict adherence to absolute stop-test criteria (SBP > 220 mmHg) during aerobic progression.
###

Track 2: Community & Public Health Path / Ruta Comunitaria y Salud Pública

Focus: County health department cardiac risk reduction program; managing blood pressure screening and safe walking interventions for community members with cardiovascular risk factors.

###
[TRACK]: Track 2 - Community & Public Health Path
[CLIENT INITIALS]: M.K. | [AGE]: 62 | [LOCATION]: Yuma County, AZ
[COMMUNITY PROFILE]: Participant in a county-sponsored municipal heart health walking initiative.
[PUBLIC HEALTH ISSUE]: Client experiences exertional dizziness and fluctuating blood pressure when walking outdoors in high ambient temperatures without proper thermal pacing and pre-exercise screening.
###

Track 3: Sports & Athletic Performance Path / Ruta de Rendimiento Deportivo

Focus: Master athlete conditioning; managing post-intervention cardiac return to play, rate-pressure product (RPP) thresholds, and high-intensity interval pacing.

###
[TRACK]: Track 3 - Sports & Athletic Performance Path
[ATHLETE INITIALS]: M.K. Jr. | [AGE]: 50 | [LOCATION]: Yuma, AZ
[ATHLETIC PROFILE]: Masters competitive cyclist returning to structured training post-percutaneous coronary intervention (PCI).
[PERFORMANCE ISSUE]: Athlete struggles with pacing intervals, risking excessive rate-pressure product elevations (> 25,000 mmHg·bpm) during steep climbs without proper heart rate reserve auditing.
###

Phase 2: Gemini AI Clinical Simulation Consultation / Espacio de Simulación con IA

"Act as my KIN-265 Clinical Exercise Specialist Preceptor in the Narrator voice. Based on the case profile wrapped in triple-hashes (###) above, perform a cardiovascular pathology and exercise safety audit strictly following PAGA 2018 (2nd Ed.) standards. First, identify the PATTERN by analyzing hemodynamic responses, medication blunting (beta-blockade), or ischemic risks. Second, apply the RULE by citing PAGA 2018 chronic condition mandates for cardiovascular disease, blood pressure limits, and absolute stop-test criteria (SBP > 220 mmHg, DBP > 105 mmHg). Third, SOLVE by designing a track-specific clinical exercise safety protocol, including a 2-sentence bilingual client instruction card in English and Spanish. Keep all case data wrapped within triple-hash delimiters."

Discussion Tasks / Tareas de Discusión (Due Thursday / Jueves 11:59 PM MST):

Identify Selected Track & Cardiovascular Risk / Ruta y Riesgo Cardiovascular: State your chosen track (Track 1 Clinical, Track 2 Community, or Track 3 Performance) and explain the specific cardiovascular vulnerability in your client scenario.
Indique la ruta seleccionada y explique la vulnerabilidad cardiovascular específica de su cliente.
Clinical Framing Protocol Audit (Pattern / Rule / Solve) / Análisis del Protocolo de Marco Clínico (Patrón / Regla / Solución): Detail the underlying physiological mechanism (Pattern), apply PAGA 2018 chronic condition safety mandates for cardiovascular disease and hemodynamic limits (Rule), and outline your clinical exercise management protocol (Solve).
Detalle el mecanismo fisiológico (Patrón), aplique las normas de la PAGA 2018 para enfermedades cardiovasculares (Regla) y describa su protocolo de manejo clínico (Solución).
Bilingual Client Instruction Card / Tarjeta de Instrucción Bilingüe: Provide a concise 2-sentence instruction card in English and Spanish guiding the client on safe exertion monitoring (using Borg RPE) or symptom recognition.
Proporcione una tarjeta concisa de 2 oraciones en inglés y en español para guiar al cliente sobre el monitoreo del esfuerzo.

Peer Engagement Requirement / Requisito de Interacción

By Sunday at 11:59 PM MST, respond to at least ONE (1) classmate who selected a different track than yours (Minimum 1 Reply Required). Compare how hemodynamic monitoring and cardiovascular safety protocols differ across clinical cardiac rehabilitation, community health screening, and master athletic performance environments.

Antes del domingo a las 11:59 PM MST, responda al menos a UN (1) compañero que haya elegido una ruta diferente a la suya (mínimo 1 respuesta). Compare cómo difiere el monitoreo hemodinámico y la seguridad cardiovascular.

Evaluation Rubric (10 Points Total • 10/7/0 Grading Scale)

Table 1: Discussion 09 Evaluation Rubric (10
Criteria / Criterio	Exemplary (100% • 10 pts) / Ejemplar	Competent (70% • 7 pts) / Competente	Recalibrate (0% • 0 pts) / Recalibrar
Step 1: Cardiovascular Audit & Clinical Framing Protocol (4.0 pts) Auditoría Cardiovascular y Protocolo de Marco Clínico (Patrón / Regla / Solución)	Accurately identifies hemodynamic/ischemic risks (Pattern), applies PAGA 2018 cardiovascular mandates and stop-tests (Rule), and designs track-specific management protocols with bilingual client cards (4.0 pts).	Identifies risks but provides superficial hemodynamic analysis, omits PAGA rules, or lacks bilingual summaries (2.8 pts).	Incomplete post, misses key prompts, or fails to submit initial post by deadline (0 pts).
Step 2: Peer Engagement & Cross-Track Analysis (4.0 pts) Interacción con Compañeros y Análisis Cruzado	Replies meaningfully to at least 2 classmates in different tracks, evaluating how hemodynamic monitoring compares across clinical, community, or sports environments (4.0 pts).	Replies to only 1 peer or offers generic praise without comparing track-specific cardiovascular strategies (2.8 pts).	Fails to reply to peers or provides off-topic responses (0 pts).
Step 3: Tone, Formatting & Delimiter Protocol (2.0 pts) Tono, Formato y Protocolo de Delimitadores	Communicates professionally using accurate clinical terminology (e.g., beta-blockade, rate-pressure product, Borg RPE, SBP stop-test) with proper bilingual markup and delimiter usage (2.0 pts).	Minor grammatical issues or isolated terminology errors, but general professional tone is maintained (1.4 pts).	Unprofessional tone, disorganized text, or complete lack of clinical terminology (0 pts).

Interactive Clinical Simulation & Outcome Gate (Module 09) / Simulación Clínica y Dominio de Resultados (Módulo 09)

Process Over Product (Clinical Framing Protocol): Every resident analysis, discussion defense, and lab submission in KIN-265 Module 09 is evaluated against the three-step clinical reasoning trail: Pattern (diagnosing the Yuma / Imperial Valley client context, environmental heat stressors, and vitals) → Rule (applying the Academic Source of Truth: ACSM 12th Ed. (Guidelines for Exercise Testing and Prescription) & PAGA 2018) → Solve (formulating an evidence-based clinical intervention and safe exercise/nutrition prescription in your own voice).

Proceso Sobre Producto (Patrón / Regla / Solución): Cada análisis, defensa en el foro y entrega de laboratorio en el Módulo 09 de KIN-265 se evalúa bajo la ruta de razonamiento clínico: Patrón (Pattern: diagnosticar el caso en Yuma / Valle Imperial y signos vitales) → Regla (Rule: aplicar la Fuente Académica de Verdad: ACSM 12th Ed. (Guías para Pruebas de Ejercicio y Prescripción) y PAGA 2018) → Solución (Solve: formular una intervención clínica segura y una prescripción práctica con tu propia voz).

###CASE_DATA_START###
Course & Module: KIN-265 • Module 09 (Mod 09 Discussion: Medical Clearance & Heart Safety Rules)
Clinical Framing Trail: Pattern (Yuma / Imperial Valley Context & Vitals) -> Rule (ACSM 12th Ed. | PAGA 2018) -> Solve (Clinical Intervention & Prescription)
FERPA & Active Verification Boundary: Verified de-identified clinical simulation record (10 / 7 / 0 Mastery Scale).
###CASE_DATA_END###

Universal Design & Accessibility / Accesibilidad Universal

English: All course materials in KIN-265 adhere strictly to Universal Design for Learning (UDL) principles and WCAG 2.1 AA standards. This page features accessible table scopes, non-LaTeX technical typography, and screen-reader verification.

Español: Todos los materiales de KIN-265 cumplen con los principios de UDL y los estándares WCAG 2.1 AA, garantizando la accesibilidad para lectores de pantalla.

AccessABILITY Resource Services (ARS) | Yuma Campus 3C Building | (928) 344-7674 | Contact: access@azwestern.edu

KIN-265 • Ejercicio para Poblaciones Especiales

Módulo 09 Foro de Discusión: Patologías Cardiovasculares y Prescripción de Ejercicio

Respuesta Hemodinámica y Normas PAGA

Analice el caso del cliente M.K. utilizando el marco del Protocolo de Encuadre Clínico (Patrón / Regla / Solución) según la ruta profesional seleccionada y envíe sus respuestas en Canvas.

Estructura de Entrega para el Foro

Parte 1: Reconocimiento de Patrones

Identifique los riesgos hemodinámicos y la interacción de medicamentos (bloqueo beta y respuesta de frecuencia cardíaca).

Parte 2: Aplicación de Reglas (Guías PAGA 2018)

Aplique los estándares de la PAGA 2018 para condiciones cardiovasculares y criterios absolutos de parada.

Parte 3: Resolución de la Brecha

Detalle el protocolo de seguridad y proporcione una tarjeta de instrucciones bilingüe en inglés y español.